ALLMedicine™ Heart Failure Center
Research & Reviews 57,980 results
ESC Heart Failure; Clephas PRD, Radhoe SP et. al.
Feb 5th, 2023 - Hyperkalaemia is observed frequently in heart failure (HF) patients and is associated with an impaired prognosis and underuse of mineralocorticoid receptor antagonists (MRAs). However, the effects of serum potassium on prescription of the full gui...
Journal of Cardiovascular Electrophysiology; Friedman DJ, Freeman JV et. al.
Feb 5th, 2023 - Although atrial fibrillation (AF) ablation has become increasingly safer, rehospitalization and emergency department (ED) evaluations can occur in the post-ablation period. Better understanding of the frequency, causes, and predictors for hospital...
Clinical Chemistry; Maya-Ramos L, Scherer PE et. al.
Feb 5th, 2023 - Small Peptide, Large Implications: Endotrophin in Heart Failure with Preserved Ejection Fraction.|2023|Maya-Ramos L,Scherer PE,de Lemos JA,|
Journal of Interventional Cardiac Electrophysiology : an ... Dhruva SS, Zhang S et. al.
Feb 5th, 2023 - The ThermoCool STSF catheter is used for ablation of ischemic ventricular tachycardia (VT) in routine clinical practice, although outcomes have not been studied and the catheter does not have Food and Drug Administration (FDA) approval for this in...
Journal of Hospital Medicine; Harrison D, Misra A et. al.
Feb 5th, 2023 - Things We do for No Reason™: Routinely obtaining repeat transthoracic echocardiography for acute decompensation of known chronic heart failure.|2023|Harrison D,Misra A,Pahwa A,Muradali K,Sherman S,|
Guidelines 94 results
Kidney International; de Boer IH, Khunti K et. al.
Oct 7th, 2022 - People with diabetes and chronic kidney disease (CKD) are at high risk for kidney failure, atherosclerotic cardiovascular disease, heart failure, and premature mortality. Recent clinical trials support new approaches to treat diabetes and CKD. The...
The Canadian Journal of Cardiology; Mancini GBJ, O'Meara E et. al.
Aug 13th, 2022 - This guideline synthesizes clinical trial data supporting the role of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter 2 inhibitors (SGLT2i) for treatment of heart failure (HF), chronic kidney disease, and for optimizing...
Journal of the American Society of Echocardiography : Off... Nagueh SF, Phelan D et. al.
Jun 7th, 2022 - Hypertrophic cardiomyopathy (HCM) is defined by the presence of left ventricular hypertrophy in the absence of other potentially causative cardiac, systemic, syndromic, or metabolic diseases. Symptoms can be related to a range of pathophysiologic ...
Heart Rhythm; Sandhu RK, Seiler A et. al.
Apr 17th, 2022 - An integrated, coordinated, and patient-centered approach to atrial fibrillation (AF) care delivery may improve outcomes and reduce cost. The purpose of this study was to gain a better understanding from key stakeholder groups on current practices...
Journal of the American College of Cardiology; Heidenreich PA, Bozkurt B et. al.
Apr 6th, 2022 - The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart F...
Drugs 2,912 results see all →
Clinicaltrials.gov 6,685 results
Feb 3rd, 2023 - This is a non-randomized, feasibility study that will enroll up to 100 participants clinically diagnosed with HFpEF or HFrEF. Approximately 70% of participants will have HFpEF and 30% will have HFrEF. There will be one study visit per participant....
Feb 3rd, 2023 - This is an observational study in which data from Japanese people with chronic heart failure who will be receiving vericiguat is studied. Chronic heart failure (HF) is a long-term condition where the heart does not pump blood as well as it should....
Feb 3rd, 2023 - Respiratory tract infections are the second global cause of disability-adjusted life years and represent a higher cost than illnesses such as heart failure, asthma, or migraine. The influenza virus is responsible for 11.5% of episodes of lower res...
Feb 3rd, 2023 - To confirm the safety of tolvaptan sodium phosphate in patients with volume overload in heart failure.
Feb 3rd, 2023 - The REVERSE-HF study is a randomized controlled trial to evaluate clinical outcomes of adjustable ultrafiltration with the Aquadex System as compared to adjustable IV loop diuretics in patients with worsening heart failure (HF) and fluid overload.
News 9,392 results
Feb 7th, 2023 - The ChatGPT artificial intelligence chatbot provided largely appropriate responses to simple cardiovascular prevention questions, though some answers lacked context and may be harmful. (JAMA) People conceived from assisted reproductive technology ...
Feb 6th, 2023 - The population undergoing mitral valve surgery has changed significantly, without a reduction in case volumes, since the arrival of transcatheter edge-to-edge repair (TEER) as a minimally invasive alternative. Nationwide, there was a downtrend in ...
Heidi Splete, MDedge News
Feb 3rd, 2023 - A restrictive fluid strategy had no significant impact on mortality in patients with sepsis-induced hypotension compared to the typical liberal fluid strategy, based on data from 1,563 individuals. Intravenous fluids are standard in the early resu.
Feb 3rd, 2023 - Anthracycline users with breast cancer or lymphoma had an upfront risk of congestive heart failure (CHF) that persisted during long-term follow-up in a population-based case-control study. The cumulative incidence of new-onset CHF was significantl...
Approximately 90% of Americans eat too much sodium. This practice leads to increased blood pressure, which increases the risk for stroke, coronary heart disease, heart failure, and renal disease. Population-based strategies to reduce sodium intake...